147 related articles for article (PubMed ID: 7627995)
1. A rat monoclonal anti-(human CD2) and L-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome.
Bombil F; Kints JP; Havaux X; Scheiff JM; Bazin H; Latinne D
Cancer Immunol Immunother; 1995 Jun; 40(6):383-9. PubMed ID: 7627995
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
3. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
Baiocchi RA; Caligiuri MA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
[TBL] [Abstract][Full Text] [Related]
4. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells.
Snanoudj R; Rouleau M; Bidère N; Carmona S; Baron C; Latinne D; Bazin H; Charpentier B; Senik A
Transplantation; 2004 Jul; 78(1):50-8. PubMed ID: 15257038
[TBL] [Abstract][Full Text] [Related]
5. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
6. Conversion of normal rats into SCID-like animals by means of bone marrow transplantation from SCID donors allows engraftment of human peripheral blood mononuclear cells.
Lubin I; Segall H; Erlich P; David M; Marcus H; Fire G; Burakova T; Kulova L; Reisner Y
Transplantation; 1995 Oct; 60(7):740-7. PubMed ID: 7570987
[TBL] [Abstract][Full Text] [Related]
7. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes.
Fox RI; Pisa P; Pisa EK; Kang HI
J Clin Lab Anal; 1993; 7(1):46-56. PubMed ID: 8381174
[TBL] [Abstract][Full Text] [Related]
9. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation.
Veronese ML; Veronesi A; D'Andrea E; Del Mistro A; Indraccolo S; Mazza MR; Mion M; Zamarchi R; Menin C; Panozzo M
J Exp Med; 1992 Dec; 176(6):1763-7. PubMed ID: 1460431
[TBL] [Abstract][Full Text] [Related]
11. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.
Dierksheide JE; Baiocchi RA; Ferketich AK; Roychowdhury S; Pelletier RP; Eisenbeis CF; Caligiuri MA; VanBuskirk AM
Blood; 2005 Feb; 105(4):1558-65. PubMed ID: 15498860
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
15. A promising model of primary human immunization in human-scid mouse.
Bombil F; Kints JP; Scheiff JM; Bazin H; Latinne D
Immunobiology; 1996 Aug; 195(3):360-75. PubMed ID: 8877409
[TBL] [Abstract][Full Text] [Related]
16. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
17. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD).
Johannessen I; Crawford DH
Rev Med Virol; 1999; 9(4):263-77. PubMed ID: 10578121
[TBL] [Abstract][Full Text] [Related]
18. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the heavy chain of antibodies that recognize the capsular polysaccharide of Neisseria meningitidis in hu-PBMC reconstituted SCID mice and in the immunized human donor.
Smithson SL; Srivastava N; Hutchins WA; Westerink MA
Mol Immunol; 1999 Feb; 36(2):113-24. PubMed ID: 10378683
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
